Agentic AI Comparison:
JobHuntr.fyi vs Tilda Bio AI

JobHuntr.fyi: 6

JobHuntr.fyi is an automation‑oriented job application bot but, based on its GitHub footprint, it is primarily a user‑driven assistant rather than a fully autonomous agent that operates unattended.[{"source":"https://github.com/lookr-fyi/job-application-bot-by-ollama-ai"}] The typical workflow for similar Ollama‑based job bots involves: (1) user providing job descriptions or links; (2) the tool generating or tailoring artifacts (resume bullets, cover letters, outreach messages); and (3) the user manually submitting applications or confirming actions. The repository does not advertise features like autonomous browser control, end‑to‑end job application submission, or persistent monitoring of job boards, which would be needed for very high autonomy. Instead, it is best described as a semi‑autonomous content generation and workflow helper. Within its scope, it likely automates repetitive text drafting and personalisation well, but it remains contingent on user prompts and supervision. Hence, it merits a mid‑to‑upper score for autonomy in content generation, but lower than enterprise “teammates” that orchestrate multiple operational systems.

Tilda Bio AI: 9

Tilda Bio AI is explicitly framed as an "AI teammate" system that performs substantive operational work in clinical trials with limited need for constant human prompting.[{"source":"https://tilda.bio/articles/why-i-built-ai-teammates-for-clinical-research"},{"source":"https://aiagentstore.ai/ai-agent/tilda-ai"}] Public descriptions emphasize high task‑specific autonomy: automating routine tasks (data entry, compliance monitoring, patient recruitment), streamlining site activation, and enabling real‑time monitoring and compliance tracking.[{"source":"https://aiagentstore.ai/ai-agent/tilda-ai"},{"source":"https://www.retinalphysician.com/issues/2025/may/ai-in-clinical-trials/"}] Case examples mention large reductions in query burden (e.g., 90% reduction in queries per visit, query close time shrinking from ~2 weeks to 2 days), implying that the system autonomously detects, flags, and in some cases resolves or helps resolve data issues and protocol deviations.[{"source":"https://www.retinalphysician.com/issues/2025/may/ai-in-clinical-trials/"}] The product is built to run continuously in the background within clinical workflows (data management, regulatory, quality assurance), which is characteristic of high autonomy in a constrained domain. It still operates under human oversight due to regulatory constraints, so a 10/10 score (full automation) would be unrealistic; however, compared to typical agentic tools, its workflow‑level autonomy is very high.

JobHuntr.fyi: 5

JobHuntr.fyi is hosted on GitHub as a code repository, which typically requires users to have basic technical competence: installing dependencies, configuring environment variables, running the app (often via command line or Docker), and setting up Ollama with the desired model.[{"source":"https://github.com/lookr-fyi/job-application-bot-by-ollama-ai"}] There is no evidence that it is offered as a one‑click SaaS or no‑code web app for non‑technical users. For developers or power users, this setup is straightforward, and once running, it can simplify the creation of job application materials. For a general audience, however, the need to self‑host and manage local LLM infrastructure reduces perceived ease of use. Documentation quality (readme, examples) can mitigate this, but the inherent DIY nature justifies a mid‑range score.

Tilda Bio AI: 8

Tilda Bio AI is delivered as a commercial solution designed for sponsors, CROs, and sites, with the explicit promise that it "seamlessly learns and integrates with your existing tools and processes" and works alongside existing workflows.[{"source":"https://tilda.bio"},{"source":"https://tilda.bio/articles/why-i-built-ai-teammates-for-clinical-research"},{"source":"https://aiagentstore.ai/ai-agent/tilda-ai"}] Marketing materials stress reduced administrative burden and simplified trial management, implying a focus on UX and workflow fit for non‑technical clinical staff. Additionally, public commentary discusses early adopters in ophthalmology seeing improved staff satisfaction due to removed repetitive tasks.[{"source":"https://www.retinalphysician.com/issues/2025/may/ai-in-clinical-trials/"}] However, as an enterprise product, initial implementation—integrating EDCs, CTMS, and regulatory systems—likely involves configuration, training, and change management. This means it is very easy to use once deployed for end users, but requires organizational coordination to get started. This justifies a high, but not perfect, ease‑of‑use score.

JobHuntr.fyi: 8

JobHuntr.fyi is open‑source and built on top of an LLM served by Ollama.[{"source":"https://github.com/lookr-fyi/job-application-bot-by-ollama-ai"}] This architecture is inherently modifiable: users can swap models, adjust prompts, fork the repository, integrate with other services (e.g., ATS APIs, scraping tools), or repurpose parts of the code for related use cases (e.g., networking outreach, LinkedIn message drafting). Although the default use case is job applications, the codebase does not appear constrained by regulatory validations or locked‑down enterprise contracts, which gives technically capable users broad flexibility. At the same time, this flexibility is mainly accessible to developers—non‑technical users see only the default behavior. Overall, the open‑source and local‑LLM foundations warrant a slightly higher flexibility score than a regulated SaaS product, especially across domains and custom modifications.

Tilda Bio AI: 7

Tilda Bio AI is designed for a specific, highly regulated domain—clinical research—and within that domain it supports multiple stakeholders (sponsors, CROs, sites) and multiple operational areas: data management, regulatory/compliance work, quality assurance, and staff productivity.[{"source":"https://tilda.bio"},{"source":"https://www.retinalphysician.com/issues/2025/may/ai-in-clinical-trials/"}] The product literature describes AI teammates with “product flavors” for sites, sponsors, and CROs, indicating some degree of configuration to different roles and workflows.[{"source":"https://www.youtube.com/watch?v=m7aokyGd01M"}] Integration with existing tools (EDC, CTMS, document management) also suggests flexible data and workflow integration.[{"source":"https://www.8vc.com/companies/tilda"}] However, this flexibility is mostly vertical: Tilda is optimized for clinical trials, not a general‑purpose agent platform for arbitrary business processes. Customization will be constrained by regulatory compliance and validated workflows, and substantial changes likely involve professional services. Thus, it is highly flexible within its niche but not broadly adaptable across unrelated domains.

JobHuntr.fyi: 9

JobHuntr.fyi is released as an open‑source GitHub project.[{"source":"https://github.com/lookr-fyi/job-application-bot-by-ollama-ai"}] There is no license fee to use the code itself. The main costs to the user are: (1) the time/effort required to set it up; (2) hardware costs if running models locally; and (3) potential opportunity cost if using paid APIs or higher‑end models instead of purely local ones. For most individual users with a capable machine and use of free/local models in Ollama, the marginal monetary cost is close to zero. This leads to a very high score for cost, representing affordability. It does not reach a perfect 10 only because some users may need to invest in suitable local hardware or pay for supplementary services if they customize heavily.

Tilda Bio AI: 4

Tilda Bio AI is a commercial, enterprise‑grade solution aimed at sponsors, CROs, and research sites, backed by venture funding and positioned as a benchmark provider in AI‑driven clinical operations with strong performance metrics (e.g., 80% cost reduction targets and 99% accuracy in their broader research platform).[{"source":"https://leadiq.com/c/tilda-research/607648f9f75c47a09122e9a8"},{"source":"https://www.8vc.com/companies/tilda"}] Publicly available sources do not list pricing, but given its target market and the complexity of integrations and regulatory context, pricing is almost certainly in the enterprise or per‑site licensing range, with implementation and support costs. While the value proposition (e.g., reduced study activation time, reduced regulatory-task time by ~50%, fewer queries) suggests substantial ROI.[{"source":"https://www.youtube.com/watch?v=m7aokyGd01M"},{"source":"https://www.retinalphysician.com/issues/2025/may/ai-in-clinical-trials/"}] the upfront and ongoing financial cost will be high relative to individual‑user tools. As the metric here is absolute affordability rather than ROI, the score remains on the lower side.

JobHuntr.fyi: 5

JobHuntr.fyi exists primarily as a GitHub repository for a job application bot.[{"source":"https://github.com/lookr-fyi/job-application-bot-by-ollama-ai"}] There is no strong evidence from the repository itself or external references in major AI directories or press indicating very broad adoption. Projects like this commonly attract a modest user base of developers and technically adept job seekers interested in local LLMs and automation workflows. Compared to widely used SaaS job‑search tools or prominent open‑source LLM frameworks, its footprint is likely smaller. As a result, it earns a mid‑range popularity score—significant enough to have a public repo and some usage, but not large‑scale or industry‑defining reach.

Tilda Bio AI: 7

Tilda Research and its AI teammates have visibility in specialized life‑sciences and health‑IT circles. Evidence includes: (1) being a portfolio company of 8VC, which lists its clinical research automation capabilities and network of US research sites;[{"source":"https://www.8vc.com/companies/tilda"}] (2) coverage in trade publications like Retinal Physician describing AI teammates in ophthalmology clinical trials;[{"source":"https://www.retinalphysician.com/issues/2025/may/ai-in-clinical-trials/"}] (3) appearances on sector‑specific podcasts such as Healthcare IT Today’s Life Sciences Today, where the founder discusses AI teammates metrics (e.g., reductions in activation timelines and regulatory time);[{"source":"https://www.youtube.com/watch?v=m7aokyGd01M"}] and (4) listings in AI tool directories / comparison sites (e.g., AI Agent Store, SaaS metric comparisons).[{"source":"https://aiagentstore.ai/ai-agent/tilda-ai"},{"source":"https://getlatka.com/companies/carallel.com/vs/tilda.bio"}] Within the relatively narrow domain of clinical trial operations, this reflects significant mindshare and adoption momentum. However, compared to mass‑market AI products, Tilda remains niche, which keeps its overall popularity score moderate.